Lataa...
Cancer neoantigens and immunogenicity: mutation position matters
Cancer mutations can elicit protective immunity. Computational methods are critical for selecting these neoantigens for immunotherapy. While significant progress has been made in the field in predicting peptide presentation, our understanding of which mutated peptide is recognized as foreign by T ce...
Tallennettuna:
| Julkaisussa: | Mol Cell Oncol |
|---|---|
| Päätekijät: | , , |
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
Taylor & Francis
2020
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7199756/ https://ncbi.nlm.nih.gov/pubmed/32391432 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/23723556.2020.1740071 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|